Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis

KA Alene, ACA Clements, ES McBryde, E Jaramillo… - Journal of Infection, 2018 - Elsevier
Background Mental health disorders, social stress, and poor health-related quality of life are
commonly reported among people with tuberculosis (TB). We conducted a systematic review …

The effects of acceptance and commitment therapy on psychosocial impact and adherence of multidrug-resistant tuberculosis patients

PP As' hab, BA Keliat… - Journal of public health …, 2022 - journals.sagepub.com
Background The Worldwide resistance prevalence of the first-line tuberculosis drug,
rifampicin, in 2017 was 7.4 per 100,000 population, and 82% of them experienced …

Study of adverse drug reactions during the treatment of drug resistant tuberculosis

DD Gupta, SJ Keny, UC Kakodkar - Indian Journal of Tuberculosis, 2024 - Elsevier
Background Pharmacovigilance entails monitoring of patients for timely detection of ADR
and reporting them so that more information about drug safety can be obtained. This may …

Ambispective study of adverse drug reactions in multi-drug resistant tuberculosis patients in Warangal, Telangana

S Fatima, MF Syeda, N Adla, R Devi - Lung India, 2021 - journals.lww.com
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a global threat
concerning to a risk of high mortality with the potential to cause adverse drug reactions …

[PDF][PDF] Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India.

MP Rupani, JD Dave, VB Parmar… - … Medical Journal of …, 2020 - researchgate.net
Background. The predictors for discontinuation of multidrug-resistant tuberculosis (MDR-TB)
regimens have not been studied in Gujarat. We aimed to find out the adverse drug reactions …

“Side effects--part of the package”: a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India

A Jakasania, K Shringarpure, D Kapadia… - BMC Infectious …, 2020 - Springer
Abstract Background High rates of Adverse Events (AEs) during treatment is one of the
leading causes of unsuccessful treatment outcomes among patients with drug resistant …

[PDF][PDF] Study on adverse drug reaction profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis cases registered under …

G Mahata, TA Rupam Kumar, P Sen… - J Evolufion Med …, 2020 - researchgate.net
BACKGROUND The emergence of drug resistant mycobacterium has become a significant
public health problem creating an obstacle to effective tuberculosis (TB) control. Freedom …

[PDF][PDF] Pattern of adverse drug reactions and its potential impact on drug resistant tuberculosis patients at a tertiary care teaching hospital in Western India

S Amin, V Mishra, D Mira, S Rajesh - Clin J Pharmacol …, 2018 - researchgate.net
Abstract Objectives: To evaluate Adverse Drug Reactions (ADRs) pattern of antitubercular
drugs and its impact on MDR & XDR-TB patients. Material & methods: An observational …

Evaluation of treatment outcomes and adverse effects of drug resistant tuberculosis patients at Larkana and Sukkur tuberculosis centres

AA Unar, A Dayo, MA Ghoto, K Unar… - Pakistan Journal of …, 2020 - pjp.pps.org.pk
Background: Anti-tuberculosis drug resistant is a major public health problem worldwide. It
arises due to improper use of anti-tuberculous drugs in susceptible TB patients. The …

[PDF][PDF] A retrospective study of adverse drug reaction in multidrug-resistant tuberculosis patients at tertiary care hospital

A Mishra, S Mathur, S Jain - Asian J Pharmaceut Clin Res, 2022 - academia.edu
Objective: The objective of the study was to the analysis of different parameters including
admission type, demographics, type of reaction, the seriousness of reaction, classification of …